237 related articles for article (PubMed ID: 23666966)
61. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
Hayase S; Sasaki Y; Matsubara T; Seo D; Miyakoshi M; Murata T; Ozaki T; Kakudo K; Kumamoto K; Ylaya K; Cheng SY; Thorgeirsson SS; Hewitt SM; Ward JM; Kimura S
Thyroid; 2015 Apr; 25(4):425-36. PubMed ID: 25647164
[TBL] [Abstract][Full Text] [Related]
62. Transforming events in thyroid tumorigenesis and their association with follicular lesions.
Heaney AP; Nelson V; Fernando M; Horwitz G
J Clin Endocrinol Metab; 2001 Oct; 86(10):5025-32. PubMed ID: 11600580
[TBL] [Abstract][Full Text] [Related]
63. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
[TBL] [Abstract][Full Text] [Related]
64. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.
Floor SL; Hebrant A; Pita JM; Saiselet M; Trésallet C; Libert F; Andry G; Dumont JE; van Staveren WC; Maenhaut C
PLoS One; 2014; 9(11):e111581. PubMed ID: 25375362
[TBL] [Abstract][Full Text] [Related]
65. CDH16/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas.
Calì G; Gentile F; Mogavero S; Pallante P; Nitsch R; Ciancia G; Ferraro A; Fusco A; Nitsch L
Endocrinology; 2012 Jan; 153(1):522-34. PubMed ID: 22028439
[TBL] [Abstract][Full Text] [Related]
66. A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis.
Matsumoto F; Fujii H; Abe M; Kajino K; Kobayashi T; Matsumoto T; Ikeda K; Hino O
Hum Pathol; 2006 Dec; 37(12):1592-600. PubMed ID: 16949643
[TBL] [Abstract][Full Text] [Related]
67. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion.
Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B
J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099
[TBL] [Abstract][Full Text] [Related]
68. Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis.
Christian JI; Pastula A; Herbst A; Neumann J; Marschall MK; Ofner A; Zierahn H; Schneider MR; Wolf E; Quante M; Kolligs FT
Oncotarget; 2022; 13():615-627. PubMed ID: 35422964
[TBL] [Abstract][Full Text] [Related]
69. PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.
Bellevicine C; Iaccarino A; Malapelle U; Sasso FC; Biondi B; Troncone G
Eur J Endocrinol; 2013 Sep; 169(3):307-11. PubMed ID: 23811186
[TBL] [Abstract][Full Text] [Related]
70. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
[TBL] [Abstract][Full Text] [Related]
71. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
[TBL] [Abstract][Full Text] [Related]
72. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
[TBL] [Abstract][Full Text] [Related]
73. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
74. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
75. AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer.
Vidal AP; Andrade BM; Vaisman F; Cazarin J; Pinto LF; Breitenbach MM; Corbo R; Caroli-Bottino A; Soares F; Vaisman M; Carvalho DP
Eur J Endocrinol; 2013 Oct; 169(4):521-8. PubMed ID: 23904275
[TBL] [Abstract][Full Text] [Related]
76. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
[TBL] [Abstract][Full Text] [Related]
77. Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell lines.
Bassi V; De Riu S; Feliciello A; Altomonte M; Allevato G; Rossi G; Fenzi GF
Thyroid; 1998 Jan; 8(1):23-8. PubMed ID: 9492149
[TBL] [Abstract][Full Text] [Related]
78. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.
Vasko V; Saji M; Hardy E; Kruhlak M; Larin A; Savchenko V; Miyakawa M; Isozaki O; Murakami H; Tsushima T; Burman KD; De Micco C; Ringel MD
J Med Genet; 2004 Mar; 41(3):161-70. PubMed ID: 14985374
[TBL] [Abstract][Full Text] [Related]
79. Clinical significance of mannose-binding lectin expression in thyroid carcinoma tissues.
Lu Y; Sun G; Liu G; Shi Y; Han Y; Yu F; Xiang X; Li W; Xiao H; Liu X; Li S
Pathol Oncol Res; 2013 Apr; 19(2):259-66. PubMed ID: 23250731
[TBL] [Abstract][Full Text] [Related]
80. PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.
Ishii J; Yazawa T; Chiba T; Shishido-Hara Y; Arimasu Y; Sato H; Kamma H
Endocrinology; 2016 Mar; 157(3):1289-98. PubMed ID: 26760117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
